Verbatim response from Perplexity
No—compounded GLP-1s are usually not the best first option. If Wegovy was denied, the safer default is to appeal the denial, check for a formulary alternative, or ask about another FDA-approved anti-obesity medication before turning to compounded products.[2][14]
Why this matters:
- The FDA does not approve compounded GLP-1s, and it does not review them for safety, effectiveness, or quality before they are sold.[2][14]
- The American Diabetes Association recommends against non-FDA-approved compounded GLP-1 and dual GIP/GLP-1 products because of uncertainty about their content and concerns about safety, quality, and effectiveness.[14]
- Reports from the FDA and other sources describe real risks, including dosing errors, quality-control problems, and adverse events with compounded GLP-1s.[5][11]
- Compounded versions may still be used in limited situations when a patient’s needs cannot be met by an FDA-approved drug, or when a medically necessary difference in formulation is documented.[1][2][13]
What I’d consider instead:
- Appeal the insurance denial if you meet the clinical criteria for Wegovy.
- Ask your clinician whether your plan covers Zepbound, Saxenda, or another FDA-approved obesity medication instead.[14]
- Check whether the denial was due to a prior authorization issue or missing documentation.
- Ask about manufacturer savings programs or a different pharmacy benefit pathway if available.
- If you still consider compounded GLP-1s, use them only with a clinician who can verify the product source and monitor you closely.[1][2][11]
When compounded GLP-1s may make sense:
- You are unable to access an FDA-approved product because of a true shortage or a documented medical need that a branded product cannot meet.[1][2][13]
- You understand that the product is not equivalent in regulatory oversight to Wegovy and may not have the same reliability of dose or purity.[2][14]
One important caveat: the FDA has said that when shortages end, compounding pharmacies generally must stop making “essentially copies” of the branded drugs, except in narrow circumstances.[2][13]
If you want, I can help you compare your realistic next options after a Wegovy denial: appeal vs switch to Zepbound vs compounded GLP-1 vs other weight-loss meds.